Calithera Biosciences to Present at Cowen and Company 37th Annual Health Care Conference
Calithera Biosciences, Inc. (CALA)
Last calithera biosciences, inc. earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
calithera.com
Company Research
Source: GlobeNewswire
SOUTH SAN FRANCISCO, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, today announced its participation at the Cowen and Company 37th Annual Health Care Conference 2017. Susan M. Molineaux, Ph.D., the company’s Founder, President and Chief Executive Officer, will present on Wednesday, March 8, 2017, at 10:00 a.m. Eastern Time in Boston, Massachusetts. The presentation will be webcast live and available for replay for up to 30 days at www.calithera.com in the Investor Relations section. About Calithera Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. Calithera’s lead product
Show less
Read more
Impact Snapshot
Event Time:
CALA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CALA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CALA alerts
High impacting Calithera Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CALA
News
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Calithera Biosciences, Inc. (NASDAQ: CALA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat